Consumption of a bifidobacterium bifidum strain for 4 weeks modulates dominant intestinal bacterial taxa and fecal butyrate in healthy adults

Applied and Environmental Microbiology

Volumn 82, Issue 19, 2016, Pages 5850-5859

  Gargari, Giorgio ^a   Taverniti, Valentina ^a   Balzaretti, Silvia ^a   Ferrario, Chiara ^a,b   Gardana, Claudio ^a   Simonetti, Paolo ^a   Guglielmetti, Simone ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

16S RRNA GENE SEQUENCING; BIFIDOBACTERIUM BIFIDUM; FECAL CONCENTRATIONS; HEALTHY INDIVIDUALS; HEALTHY VOLUNTEERS; INTERVENTION STUDIES; MICROBIAL ECO SYSTEM; SHORT CHAIN FATTY ACIDS (SCFAS);

FATTY ACIDS;

ADULT; BACTERIUM; FATTY ACID; GENETIC ANALYSIS; MICROBIAL COMMUNITY; PROBIOTICS; RELATIVE ABUNDANCE;

BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM BIFIDUM; PREVOTELLA; PREVOTELLACEAE; RIKENELLACEAE;

BACTERIAL RNA; BUTYRIC ACID; PROBIOTIC AGENT; RNA 16S;

ADULT; BIFIDOBACTERIUM BIFIDUM; CHEMISTRY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FECES; FEMALE; GENETICS; HUMAN; INTESTINE FLORA; MALE; METABOLISM; MICROBIOLOGY; MIDDLE AGED; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADULT; BIFIDOBACTERIUM BIFIDUM; BUTYRIC ACID; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; MALE; MIDDLE AGED; PROBIOTICS; RNA, BACTERIAL; RNA, RIBOSOMAL, 16S; YOUNG ADULT;

EID: 84987915653     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01753-16     Document Type: Article

References (73)

1. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME. 2014. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506-514.
2. Food Safety Authority of Ireland. Guidance on the implementation of Regulation 1924/2006 no. 1924/2006 on nutrition and health claims made on foods conclusions of the standing committee on the food chain and animal health. Food Safety Authority of Ireland, Dublin, Ireland. https://www.fsai.ie/uploadedFiles/EU_guidance:ClaimsRegulation.pdf.
3. Sanders ME, Guarner F, Guerrant R, Holt PR, Quigley EM, Sartor RB, Sherman PM, Mayer EA. 2013. An update on the use and investigation of probiotics in health and disease. Gut 62:787-796. http://dx.doi.org/10.1136/gutjnl-2012-302504.
4. Kristensen NB, Bryrup T, Allin KH, Nielsen T, Hansen TH, Pedersen O. 2016. Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med 8:52. http://dx.doi.org/10.1186/s13073-016-0300-5.
5. Goulet O. 2015. Potential role of the intestinal microbiota in programming health and disease. Nutr Rev 73(Suppl 1):S32-S40.
6. Ferrario C, Taverniti V, Milani C, Fiore W, Laureati M, De Noni I, Stuknyte M, Chouaia B, Riso P, Guglielmetti S. 2014. Modulation of fecal Clostridiales bacteria and butyrate by probiotic intervention with Lactobacillus paracasei DG varies among healthy adults. J Nutr 144:1787-1796. http://dx.doi.org/10.3945/jn.114.197723.
7. Veiga P, Pons N, Agrawal A, Oozeer R, Guyonnet D, Brazeilles R, Faurie JM, van Hylckama Vlieg JE, Houghton LA, Whorwell PJ, Ehrlich SD, Kennedy SP. 2014. Changes of the human gut microbiome induced by a fermented milk product. Sci Rep 4:6328. http://dx.doi.org/10.1038/srep06328.
8. Derrien M, van Hylckama Vlieg JE. 2015. Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol 23:354-366. http://dx.doi.org/10.1016/j.tim.2015.03.002.
9. Turroni F, Duranti S, Bottacini F, Guglielmetti S, Van Sinderen D, Ventura M. 2014. Bifidobacterium bifidum as an example of a specialized human gut commensal. Front Microbiol 5:437.
10. Guglielmetti S, Tamagnini I, Mora D, Minuzzo M, Scarafoni A, Arioli S, Hellman J, Karp M, Parini C. 2008. Implication of an outer surface lipoprotein in adhesion of Bifidobacterium bifidum to Caco-2 cells. Appl Environ Microbiol 74:4695-4702. http://dx.doi.org/10.1128/AEM.00124-08.
11. Serafini F, Strati F, Ruas-Madiedo P, Turroni F, Foroni E, Duranti S, Milano F, Perotti A, Viappiani A, Guglielmetti S, Buschini A, Margolles A, van Sinderen D, Ventura M. 2013. Evaluation of adhesion properties and antibacterial activities of the infant gut commensal Bifidobacterium bifidum PRL2010. Anaerobe 21:9-17. http://dx.doi.org/10.1016/j.anaerobe.2013.03.003.
12. Turroni F, Serafini F, Foroni E, Duranti S, O'Connell Motherway M, Taverniti V, Mangifesta M, Milani C, Viappiani A, Roversi T, Sanchez B, Santoni A, Gioiosa L, Ferrarini A, Delledonne M, Margolles A, Piazza L, Palanza P, Bolchi A, Guglielmetti S, van Sinderen D, Ventura M. 2013. Role of sortase-dependent pili of Bifidobacterium bifidum PRL2010 in modulating bacterium-host interactions. Proc Natl Acad Sci U S A 110:11151-11156. http://dx.doi.org/10.1073/pnas.1303897110.
13. López P, Gonzalez-Rodriguez I, Sanchez B, Ruas-Madiedo P, Suarez A, Margolles A, Gueimonde M. 2012. Interaction of Bifidobacterium bifidum LMG13195 with HT29 cells influences regulatory-T-cell-associated chemokine receptor expression. Appl Environ Microbiol 78:2850-2857. http://dx.doi.org/10.1128/AEM.07581-11.
14. Guglielmetti S, Zanoni I, Balzaretti S, Miriani M, Taverniti V, De Noni I, Presti I, Stuknyte M, Scarafoni A, Arioli S, Iametti S, Bonomi F, Mora D, Karp M, Granucci F. 2014. Murein lytic enzyme TgaA of Bifidobacterium bifidum MIMBb75 modulates dendritic cell maturation through its cysteine-and histidine-dependent amidohydrolase/peptidase (CHAP) amidase domain. Appl Environ Microbiol 80:5170-5177. http://dx.doi.org/10.1128/AEM.00761-14.
15. Wada J, Ando T, Kiyohara M, Ashida H, Kitaoka M, Yamaguchi M, Kumagai H, Katayama T, Yamamoto K. 2008. Bifidobacterium bifidum lacto-N-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure. Appl Environ Microbiol 74: 3996-4004. http://dx.doi.org/10.1128/AEM.00149-08.
16. Duranti S, Milani C, Lugli GA, Turroni F, Mancabelli L, Sanchez B, Ferrario C, Viappiani A, Mangifesta M, Mancino W, Gueimonde M, Margolles A, van Sinderen D, Ventura M. 2015. Insights from genomes of representatives of the human gut commensal Bifidobacterium bifidum. Environ Microbiol 17:2515-2531. http://dx.doi.org/10.1111/1462-2920.12743.
17. Cardona S, Eck A, Cassellas M, Gallart M, Alastrue C, Dore J, Azpiroz F, Roca J, Guarner F, Manichanh C. 2012. Storage conditions of intestinal microbiota matter in metagenomic analysis. BMC Microbiol 12:158. http://dx.doi.org/10.1186/1471-2180-12-158.
18. Milani C, Hevia A, Foroni E, Duranti S, Turroni F, Lugli GA, Sanchez B, Martín R, Gueimonde M, van Sinderen D, Margolles A, Ventura M. 2013. Assessing the fecal microbiota: an optimized ion torrent 16S rRNA gene-based analysis protocol. PLoS One 8:e68739. http://dx.doi.org/10.1371/journal.pone.0068739.
19. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Pena AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. 2010. QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7:335-336. http://dx.doi.org/10.1038/nmeth.f.303.
20. Huda-Faujan N, Abdulamir AS, Fatimah AB, Anas OM, Shuhaimi M, Yazid AM, Loong YY. 2010. The impact of the level of the intestinal short chain fatty acids in inflammatory bowel disease patients versus healthy subjects. Open Biochem J 4:53-58. http://dx.doi.org/10.2174/1874091X01004010053.
21. Royston P. 1993. A pocket-calculator algorithm for the Shapiro-Francia test for non-normality: an application to medicine. Stat Med 12:181-184. http://dx.doi.org/10.1002/sim.4780120209.
22. Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, Bertalan M, Borruel N, Casellas F, Fernandez L, Gautier L, Hansen T, Hattori M, Hayashi T, Kleerebezem M, Kurokawa K, Leclerc M, Levenez F, Manichanh C, Nielsen HB, Nielsen T, Pons N, Poulain J, Qin J, Sicheritz-Ponten T, Tims S, Torrents D, Ugarte E, Zoetendal EG, Wang J, Guarner F, Pedersen O, de Vos WM, Brunak S, Doré J, MetaHIT Consortium, Antolín M, Artiguenave F, Blottiere HM, Almeida M, Brechot C, Cara C, Chervaux C, Cultrone A, Delorme C, Denariaz G, et al. 2011. Enterotypes of the human gut microbiome. Nature 473:174-180. http://dx.doi.org/10.1038/nature09944.
23. Turroni F, Milani C, van Sinderen D, Ventura M. 2011. Genetic strategies for mucin metabolism in Bifidobacterium bifidum PRL2010: an example of possible human-microbe co-evolution. Gut Microbes 2:183-189. http://dx.doi.org/10.4161/gmic.2.3.16105.
24. Ashida H, Miyake A, Kiyohara M, Wada J, Yoshida E, Kumagai H, Katayama T, Yamamoto K. 2009. Two distinct alpha-L-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates. Glycobiology 19:1010-1017. http://dx.doi.org/10.1093/glycob/cwp082.
25. González-Rodríguez I, Sánchez B, Ruiz L, Turroni F, Ventura M, Ruas-Madiedo P, Gueimonde M, Margolles A. 2012. Role of extracellular transaldolase from Bifidobacterium bifidum in mucin adhesion and aggregation. Appl Environ Microbiol 78:3992-3998. http://dx.doi.org/10.1128/AEM.08024-11.
26. Ministero della Salute. 2013. Guidelines on probiotics and prebiotics. Revision May 2013. Ministero della Salute, Rome, Italy. http://www.salute.gov.it/imgs/C_17_pubblicazioni_1016_ulterioriallegati _ulterioreallegato_0_alleg.pdf.
27. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, Magris M, Hidalgo G, Baldassano RN, Anokhin AP, Heath AC, Warner B, Reeder J, Kuczynski J, Caporaso JG, Lozupone CA, Lauber C, Clemente JC, Knights D, Knight R, Gordon JI. 2012. Human gut microbiome viewed across age and geography. Nature 486: 222-227.
28. Davenport ER, Mizrahi-Man O, Michelini K, Barreiro LB, Ober C, Gilad Y. 2014. Seasonal variation in human gut microbiome composition. PLoS One 9:e90731. http://dx.doi.org/10.1371/journal.pone.0090731.
29. Knights D, Ward TL, McKinlay CE, Miller H, Gonzalez A, McDonald D, Knight R. 2014. Rethinking "enterotypes." Cell Host Microbe 16:433-437. http://dx.doi.org/10.1016/j.chom.2014.09.013.
30. Gorvitovskaia A, Holmes SP, Huse SM. 2016. Interpreting Prevotella and Bacteroides as biomarkers of diet and lifestyle. Microbiome 4:15. http://dx.doi.org/10.1186/s40168-016-0160-7.
31. Wang J, Linnenbrink M, Künzel S, Fernandes R, Nadeau MJ, Rosenstiel P, Baines JF. 2014. Dietary history contributes to enterotype-like clustering and functional metagenomic content in the intestinal microbiome of wild mice. Proc Natl Acad Sci U S A 111:E2703-E2710. http://dx.doi.org/10.1073/pnas.1402342111.
32. Vandeputte D, Falony G, Vieira-Silva S, Tito RY, Joossens M, Raes J. 2016. Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates. Gut 65:57-62. http://dx.doi.org/10.1136/gutjnl-2015-309618.
33. Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R, Sinha R, Gilroy E, Gupta K, Baldassano R, Nessel L, Li H, Bushman FD, Lewis JD. 2011. Linking long-term dietary patterns with gut microbial enterotypes. Science 334: 105-108. http://dx.doi.org/10.1126/science.1208344.
34. Kim SW, Suda W, Kim S, Oshima K, Fukuda S, Ohno H, Morita H, Hattori M. 2013. Robustness of gut microbiota of healthy adults in response to probiotic intervention revealed by high-throughput pyrosequencing. DNA Res 20:241-253. http://dx.doi.org/10.1093/dnares/dst006.
35. Dotterud CK, Avershina E, Sekelja M, Simpson MR, Rudi K, Storro O, Johnsen R, Oien T. 2015. Does maternal perinatal probiotic supplementation alter the intestinal microbiota of mother and child? J Pediatr Gastroenterol Nutr 61:200-207. http://dx.doi.org/10.1097/MPG.0000000000000781.
36. Lozupone CA, Stombaugh JI, Gordon JI, Jansson JK, Knight R. 2012. Diversity, stability and resilience of the human gut microbiota. Nature 489:220-230. http://dx.doi.org/10.1038/nature11550.
37. Gosalbes MJ, Durban A, Pignatelli M, Abellan JJ, Jimenez-Hernandez N, Perez-Cobas AE, Latorre A, Moya A. 2011. Metatranscriptomic approach to analyze the functional human gut microbiota. PLoS One 6:e17447. http://dx.doi.org/10.1371/journal.pone.0017447.
38. Flint HJ, Bayer EA, Rincon MT, Lamed R, White BA. 2008. Polysaccharide utilization by gut bacteria: potential for new insights from genomic analysis. Nat Rev Microbiol 6:121-131. http://dx.doi.org/10.1038/nrmicro1817.
39. Wang F, Yu T, Huang G, Cai D, Liang X, Su H, Zhu Z, Li D, Yang Y, Shen P, Mao R, Yu L, Zhao M, Li Q. 2015. Gut microbiota community and its assembly associated with age and diet in Chinese centenarians. J Microbiol Biotechnol 25:1195-1204. http://dx.doi.org/10.4014/jmb.1410.10014.
40. Salonen A, Lahti L, Salojarvi J, Holtrop G, Korpela K, Duncan SH, Date P, Farquharson F, Johnstone AM, Lobley GE, Louis P, Flint HJ, de Vos WM. 2014. Impact of diet and individual variation on intestinal microbiota composition and fermentation products in obese men. ISME J 8:2218-2230. http://dx.doi.org/10.1038/ismej.2014.63.
41. Martínez I, Lattimer JM, Hubach KL, Case JA, Yang J, Weber CG, Louk JA, Rose DJ, Kyureghian G, Peterson DA, Haub MD, Walter J. 2013. Gut microbiome composition is linked to whole grain-induced immunological improvements. ISME J 7:269-280. http://dx.doi.org/10.1038/ismej.2012.104.
42. West CE, Ryden P, Lundin D, Engstrand L, Tulic MK, Prescott SL. 2015. Gut microbiome and innate immune response patterns in IgEassociated eczema. Clin Exp Allergy 45:1419-1429. http://dx.doi.org/10.1111/cea.12566.
43. Chen Y, Guo J, Qian G, Fang D, Shi D, Guo L, Li L. 2015. Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality. J Gastroenterol Hepatol 30:1429-1437. http://dx.doi.org/10.1111/jgh.12932.
44. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, Jarnerot G, Tysk C, Jansson JK, Engstrand L. 2010. A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes. Gastroenterology 139:1844.e1-1854.e1. http://dx.doi.org/10.1053/j.gastro.2010.08.049.
45. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, Reyes JA, Shah SA, LeLeiko N, Snapper SB, Bousvaros A, Korzenik J, Sands BE, Xavier RJ, Huttenhower C. 2012. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol 13:R79. http://dx.doi.org/10.1186/gb-2012-13-9-r79.
46. Dinh DM, Volpe GE, Duffalo C, Bhalchandra S, Tai AK, Kane AV, Wanke CA, Ward HD. 2015. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection. J Infect Dis 211:19-27. http://dx.doi.org/10.1093/infdis/jiu409.
47. Scaldaferri F, Lopetuso L, Pecere S, Petito V, Schiavoni E, Gerardi V, Laterza L, Pistone MT, D'Ambrosio D, Ricca O, D'Agostino A, Zambrano D, Paroni Sterbini F, Gaetani E, Franceschi F, Cammarota G, Sanguinetti M, Masucci L, Gasbarrini A. 2015. Gut microbiota molecular spectrum in healthy controls, diverticular disease, IBS and IBD patients: time for microbial marker of gastrointestinal disorders? J Crohns Colitis 9:S443. http://dx.doi.org/10.1093/ecco-jcc/jju027.842.
48. Costello ME, Ciccia F, Willner D, Warrington N, Robinson PC, Gardiner B, Marshall M, Kenna TJ, Triolo G, Brown MA. 2015. Intestinal dysbiosis in ankylosing spondylitis. Arthritis Rheumatol 67:686-691. http://dx.doi.org/10.1002/art.38967.
49. Clemente-Postigo M, Queipo-Ortuno MI, Boto-Ordonez M, Coin-Araguez L, Roca-Rodriguez MM, Delgado-Lista J, Cardona F, Andres-Lacueva C, Tinahones FJ. 2013. Effect of acute and chronic red wine consumption on lipopolysaccharide concentrations. Am J Clin Nutr 97: 1053-1061. http://dx.doi.org/10.3945/ajcn.112.051128.
50. Karl JP, Fu X, Wang X, Zhao Y, Shen J, Zhang C, Wolfe BE, Saltzman E, Zhao L, Booth SL. 2015. Fecal menaquinone profiles of overweight adults are associated with gut microbiota composition during a gut microbiota-targeted dietary intervention. Am J Clin Nutr 102:84-93. http://dx.doi.org/10.3945/ajcn.115.109496.
51. Biedermann L, Brulisauer K, Zeitz J, Frei P, Scharl M, Vavricka SR, Fried M, Loessner MJ, Rogler G, Schuppler M. 2014. Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH. Inflamm Bowel Dis 20:1496-1501. http://dx.doi.org/10.1097/MIB.0000000000000129.
52. De Filippo C, Cavalieri D, Di Paola M, Ramazzotti M, Poullet JB, Massart S, Collini S, Pieraccini G, Lionetti P. 2010. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci U S A 107:14691-14696. http://dx.doi.org/10.1073/pnas.1005963107.
53. De Filippis F, Pellegrini N, Vannini L, Jeffery IB, La Storia A, Laghi L, Serrazanetti DI, Di Cagno R, Ferrocino I, Lazzi C, Turroni S, Cocolin L, Brigidi P, Neviani E, Gobbetti M, O'Toole PW, Ercolini D. 2015. High-level adherence to a Mediterranean diet beneficially impacts the gut microbiota and associated metabolome. Gut http://dx.doi.org/10.1136/gutjnl-2015-309957.
54. Scheperjans F, Aho V, Pereira PA, Koskinen K, Paulin L, Pekkonen E, Haapaniemi E, Kaakkola S, Eerola-Rautio J, Pohja M, Kinnunen E, Murros K, Auvinen P. 2015. Gut microbiota are related to Parkinson's disease and clinical phenotype. Mov Disord 30:350-358. http://dx.doi.org/10.1002/mds.26069.
55. Zhang H, DiBaise JK, Zuccolo A, Kudrna D, Braidotti M, Yu Y, Parameswaran P, Crowell MD, Wing R, Rittmann BE, Krajmalnik-Brown R. 2009. Human gut microbiota in obesity and after gastric bypass. Proc Natl Acad Sci U S A 106:2365-2370. http://dx.doi.org/10.1073/pnas.0812600106.
56. Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L, Smith JD, DiDonato JA, Chen J, Li H, Wu GD, Lewis JD, Warrier M, Brown JM, Krauss RM, Tang WH, Bushman FD, Lusis AJ, Hazen SL. 2013. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19:576-585. http://dx.doi.org/10.1038/nm.3145.
57. Elinav E, Strowig T, Kau AL, Henao-Mejia J, Thaiss CA, Booth CJ, Peaper DR, Bertin J, Eisenbarth SC, Gordon JI, Flavell RA. 2011. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145:745-757. http://dx.doi.org/10.1016/j.cell.2011.04.022.
58. Lucke K, Miehlke S, Jacobs E, Schuppler M. 2006. Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. J Med Microbiol 55:617-624. http://dx.doi.org/10.1099/jmm.0.46198-0.
59. Chen W, Liu F, Ling Z, Tong X, Xiang C. 2012. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One 7:e39743. http://dx.doi.org/10.1371/journal.pone.0039743.
60. Rigsbee L, Agans R, Shankar V, Kenche H, Khamis HJ, Michail S, Paliy O. 2012. Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome. Am J Gastroenterol 107: 1740-1751. http://dx.doi.org/10.1038/ajg.2012.287.
61. Scher JU, Sczesnak A, Longman RS, Segata N, Ubeda C, Bielski C, Rostron T, Cerundolo V, Pamer EG, Abramson SB, Huttenhower C, Littman DR. 2013. Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. eLife 2:e01202. http://dx.doi.org/10.7554/eLife.01202.
62. Kovatcheva-Datchary P, Nilsson A, Akrami R, Lee YS, De Vadder F, Arora T, Hallen A, Martens E, Björck I, Bäckhed F. 2015. Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of Prevotella. Cell Metab 22:971-982. http://dx.doi.org/10.1016/j.cmet.2015.10.001.
63. Brown CT, Davis-Richardson AG, Giongo A, Gano KA, Crabb DB, Mukherjee N, Casella G, Drew JC, Ilonen J, Knip M, Hyoty H, Veijola R, Simell T, Simell O, Neu J, Wasserfall CH, Schatz D, Atkinson MA, Triplett EW. 2011. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One 6:e25792. http://dx.doi.org/10.1371/journal.pone.0025792.
64. Kang DW, Park JG, Ilhan ZE, Wallstrom G, Labaer J, Adams JB, Krajmalnik-Brown R. 2013. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One 8:e68322. http://dx.doi.org/10.1371/journal.pone.0068322.
65. Son JS, Zheng LJ, Rowehl LM, Tian X, Zhang Y, Zhu W, Litcher-Kelly L, Gadow KD, Gathungu G, Robertson CE, Ir D, Frank DN, Li E. 2015. Comparison of fecal microbiota in children with autism spectrum disorders and neurotypical siblings in the Simons Simplex collection. PLoS One 10:e0137725. http://dx.doi.org/10.1371/journal.pone.0137725.
66. Ley RE. 2016. Gut microbiota in 2015: Prevotella in the gut: choose carefully. Nat Rev Gastroenterol Hepatol 13:69-70. http://dx.doi.org/10.1038/nrgastro.2016.4.
67. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. 2013. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54:2325-2340. http://dx.doi.org/10.1194/jlr. R036012.
68. Bourdu S, Dapoigny M, Chapuy E, Artigue F, Vasson MP, Dechelotte P, Bommelaer G, Eschalier A, Ardid D. 2005. Rectal instillation of butyrate provides a novel clinically relevant model of noninflammatory colonic hypersensitivity in rats. Gastroenterology 128:1996-2008. http://dx.doi.org/10.1053/j.gastro.2005.03.082.
69. Jeffery IB, O'Toole PW, Ohman L, Claesson MJ, Deane J, Quigley EM, Simren M. 2012. An irritable bowel syndrome subtype defined by speciesspecific alterations in faecal microbiota. Gut 61:997-1006. http://dx.doi.org/10.1136/gutjnl-2011-301501.
70. Teixeira TF, Grzeskowiak L, Franceschini SC, Bressan J, Ferreira CL, Peluzio MC. 2013. Higher level of faecal SCFA in women correlates with metabolic syndrome risk factors. Br J Nutr 109:914-919. http://dx.doi.org/10.1017/S0007114512002723.
71. Payne AN, Chassard C, Zimmermann M, Muller P, Stinca S, Lacroix C. 2011. The metabolic activity of gut microbiota in obese children is increased compared with normal-weight children and exhibits more exhaustive substrate utilization. Nutr Diabetes 1:e12. http://dx.doi.org/10.1038/nutd.2011.8.
72. Conlon MA, Bird AR, Clarke JM, Le Leu RK, Christophersen CT, Lockett TJ, Topping DL. 2015. Lowering of large bowel butyrate levels in healthy populations is unlikely to be beneficial. J Nutr 145:1030-1031. http://dx.doi.org/10.3945/jn.114.209460.
73. Guglielmetti S, Riso P. 2015. Reply to Conlon et al. J Nutr 145:1031-1032. http://dx.doi.org/10.3945/jn.114.209890.